CA Patent

CA2536192A1 — Soft tissue implants and anti-scarring agents

Assigned to Angiotech International AG · Expires 2005-06-09 · 21y expired

What this patent protects

Published without an Abstract

USPTO Abstract

Published without an Abstract

Drugs covered by this patent

Abilify (aripiprazole) · Generic (originally Otsuka/BMS)

Patent Metadata

Patent number: CA2536192A1
Jurisdiction: CA
Classification: —
Expires: 2005-06-09
Drug substance claim: No
Drug product claim: No
Assignee: Angiotech International AG
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.